Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B-Reference-Cited by-同舟云学术

Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B

Published:2014-04-21 Issue:2 Volume:22 Page:94-102
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Yasui S.¹,Fujiwara K.¹,Nakamura M.¹,Miyamura T.¹,Yonemitsu Y.¹,Mikata R.¹,Arai M.¹,Kanda T.¹,Imazeki F.¹,Oda S.²,Yokosuka O.¹

Affiliation:

1. Department of Gastroenterology and Nephrology; Graduate School of Medicine; Chiba University; Chiba Japan

2. Department of Emergency and Critical Care Medicine; Graduate School of Medicine; Chiba University; Chiba Japan

Funder

Ministry of Health, Labor and Welfare of Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12258/fullpdf

Reference26 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

2. Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection;Tsang;Aliment Pharmacol Ther,2001

3. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice;Chan;J Viral Hepat,2002

4. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B;Tsubota;J Gastroenterol Hepatol,2005

5. Tsubouchi H Oketani M Ido A Fulminant hepatitis and late onset hepatic failure (LOHF) in Japan (2009) Annual Report of the Intractable Hepato-Biliary Diseases Study Group of Japan Supported by the Ministry of Health, Labor, and Welfare 2011 96 113

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thirty‐two years' experience of treating fulminant hepatitis in a Japanese single center;Hepatology Research;2023-01-10

2. Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapy;European Journal of Medical Research;2022-11-14

3. Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapy;2022-09-15

4. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

5. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation;Alimentary Pharmacology & Therapeutics;2021-07-19